retatrutide clinical trial results obesity Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a Retatrutide Safety, Side Effects &

doi: 10.1016/S0140-6736(02)07952-7

The GLP-1 market represents a major therapeutic class by revenue in the United States pharmaceutical landscape, with continued expansion expected

Gastric Bypass Gastric bypass is a restrictive surgery technique that also alters the digestive process

As an investigational medicine, it must not be used outside of regulated clinical trial settings during pregnancy or breastfeeding

It also provides the statistical power to perform meaningful subgroup analyses, examining how the drug performs in patients with diabetes versus those without, in older versus younger patients, and in different BMI categories